{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T13:32:49Z","timestamp":1784986369805,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T00:00:00Z","timestamp":1553126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T00:00:00Z","timestamp":1553126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1007\/s00198-019-04890-2","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T15:03:01Z","timestamp":1553180581000},"page":"1187-1194","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis"],"prefix":"10.1007","volume":"30","author":[{"given":"N.B.","family":"Watts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Hattersley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.C.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Cosman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,21]]},"reference":[{"key":"4890_CR1","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R (2014) Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int 25:2359\u20132381","journal-title":"Osteoporos Int"},{"key":"4890_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1359\/jbmr.061113","volume":"22","author":"R Burge","year":"2007","unstructured":"Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. JBMR 22:465\u2013475","journal-title":"JBMR"},{"key":"4890_CR3","doi-asserted-by":"publisher","first-page":"c3324","DOI":"10.1136\/bmj.c3324","volume":"341","author":"BJ Edwards","year":"2010","unstructured":"Edwards BJ, Song J, Dunlop DD, Fink HA, Cauley JA (2010) Functional decline after incident wrist fractures-study of osteoporotic fractures: prospective cohort study. BMJ 341:c3324","journal-title":"BMJ"},{"key":"4890_CR4","first-page":"162","volume":"3","author":"A Litwic","year":"2014","unstructured":"Litwic A, Lekarz, Warwick D, Dennison E (2014) Distal radius fracture: cinderella of the osteoporotic fractures. Orthopedic Muscul Syst 3:162","journal-title":"Orthopedic Muscul Syst"},{"key":"4890_CR5","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1053\/jhsu.2002.36995","volume":"27A","author":"TD Rozental","year":"2002","unstructured":"Rozental TD, Branas CC, Bozentka DJ, Beredjiklian PK (2002) Survival among elderly patients after fractures of the distal radius. J Hand Surg 27A:948\u2013952","journal-title":"J Hand Surg"},{"key":"4890_CR6","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00198-007-0508-8","volume":"19","author":"E Barrett-Connor","year":"2008","unstructured":"Barrett-Connor E, Sajjan SG, Siris ES, Miller PD, Chen YT, Markson LE (2008) Wrist fracture as a predictor of future fractures in younger versus older postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int 19:607\u2013613","journal-title":"Osteoporos Int"},{"key":"4890_CR7","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1002\/jbmr.2559","volume":"30","author":"CJ Crandall","year":"2015","unstructured":"Crandall CJ, Hovey KM, Cauley JA, Andrews CA, Curtis JR, Wactawski-Wende J, Wright NC, Li W, LeBoff MS (2015) Wrist fracture and risk of subsequent fracture: findings from the Women\u2019s Health Initiative Study. J Bone Miner Res 30:2086\u20132095","journal-title":"J Bone Miner Res"},{"key":"4890_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s001980050172","volume":"9","author":"MT Cuddihy","year":"1999","unstructured":"Cuddihy MT, Gabriel SE, Crowson CS, O'Fallon WM, Melton LJ III (1999) Forearm fractures as predictors of subsequent osteoporotic fractures. Osteoporos Int 9:469\u2013475","journal-title":"Osteoporos Int"},{"key":"4890_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1148\/radiology.219.1.r01ap1311","volume":"219","author":"CA Goldfarb","year":"2001","unstructured":"Goldfarb CA, Yin Y, Gilula LA, Fisher AJ, Boyer MI (2001) Wrist fractures: what the clinician wants to know. Radiology 219:11\u201328","journal-title":"Radiology"},{"key":"4890_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/BF02546396","volume":"20","author":"RA Schlenker","year":"1976","unstructured":"Schlenker RA, von Seggen WW (1976) The distribution of cortical and trabecular bone mass along the lengths of the radius and ulna and its implications for in vivo bone mass measurements. Calcif Tissue Res 20:41\u201352","journal-title":"Calcif Tissue Res"},{"key":"4890_CR11","unstructured":"International Society for Clinical Densitometry. 2015 Official positions. Available at \n                  https:\/\/www.iscd.org\/official-positions\/\n                  \n                . Accessed November 20, 2017"},{"key":"4890_CR12","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/jbmr.3299","volume":"33","author":"E Biver","year":"2018","unstructured":"Biver E, Durosier-Izart C, Chevalley T, van Rietbergen B, Rizzoli R, Ferrari S (2018) Evaluation of radius microstructure and areal bone mineral density improves fracture prediction in postmenopausal women. J Bone Miner Res 33:328\u2013337","journal-title":"J Bone Miner Res"},{"key":"4890_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1210\/en.2015-1726","volume":"157","author":"G Hattersley","year":"2016","unstructured":"Hattersley G, Dean T, Corbin BA, Bahar H, Gardella TJ (2016) Binding selectivity of abaloparatide for PTH-type-1-receptor conformations and effects on downstream signaling. Endocrinology 157:141\u2013149","journal-title":"Endocrinology"},{"key":"4890_CR14","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1210\/jc.2014-3718","volume":"100","author":"BZ Leder","year":"2014","unstructured":"Leder BZ, O\u2019Dea LSL, Zanchetta JR, Kumar P, Banks K, McKay K, Lyttle CR, Hattersley G (2014) Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 100:697\u2013706","journal-title":"J Clin Endocrinol Metab"},{"key":"4890_CR15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00223-016-0171-1","volume":"99","author":"H Bahar","year":"2016","unstructured":"Bahar H, Gallacher K, Downall J, Nelson CA, Shomali M, Hattersley G (2016) Six weeks of daily abaloparatide treatment increased vertebral and femoral bone mineral density, microarchitecture and strength in osteopenic ovariectomized rats. Calcif Tissue Int 99:489\u2013499","journal-title":"Calcif Tissue Int"},{"key":"4890_CR16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00198-017-4323-6","volume":"29","author":"N Doyle","year":"2018","unstructured":"Doyle N, Varela A, Haile S, Guldberg R, Kostenuik PJ, Ominsky MS, Smith SY, Hattersley G (2018) Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption. Osteoporos Int 29:685\u2013697","journal-title":"Osteoporos Int"},{"key":"4890_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/jbmr.3003","volume":"32","author":"A Varela","year":"2017","unstructured":"Varela A, Chouinard L, Lesage E, Smith SY, Hattersley G (2017) One year of abaloparatide, a selective activator of the PTH1 receptor, increased bone formation and bone mass in ovariectomized osteopenic rats without increasing bone resorption. J Bone Miner Res 32:24\u201333","journal-title":"J Bone Miner Res"},{"key":"4890_CR18","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00198-017-4304-9","volume":"29","author":"JP Bilezikian","year":"2018","unstructured":"Bilezikian JP, Hattersley G, Fitzpatrick LA, Harris AG, Shevroja E, Banks K, Leder BZ, Zanchetta JR, Hans D (2018) Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial. Osteoporos Int 29:323\u2013328","journal-title":"Osteoporos Int"},{"key":"4890_CR19","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1001\/jama.2016.11136","volume":"316","author":"PD Miller","year":"2016","unstructured":"Miller PD, Hattersley G, Riis BJ, Williams GC, Lau E, Russo LA, Alexandersen P, Zerbini CA, Hu MY, Harris AG, Fitzpatrick LA, Cosman F, Christiansen C, Study Investigators ACTIVE (2016) Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis. JAMA 316:722\u2013733","journal-title":"JAMA"},{"key":"4890_CR20","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1089\/jwh.2008.0888","volume":"17","author":"ML Bareither","year":"2008","unstructured":"Bareither ML, Grabiner MD, Troy KL (2008) Habitual site-specific upper extremity loading is associated with increased bone mineral of the ultradistal radius in young women. J Women\u2019s Health 17:1577\u20131581","journal-title":"J Women\u2019s Health"},{"key":"4890_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1359\/jbmr.2001.16.1.157","volume":"16","author":"DB Burr","year":"2001","unstructured":"Burr DB, Hirano T, Turner CH, Hotchkiss C, Brommage R, Hock JM (2001) Intermittently administered human parathyroid hormone (1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys. J Bone Miner Res 16:157\u2013165","journal-title":"J Bone Miner Res"},{"key":"4890_CR22","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1359\/JBMR.040112","volume":"19","author":"M Sato","year":"2004","unstructured":"Sato M, Westmore M, Ma YL, Schmidt A, Zeng QQ, Glass EV, Vahle J, Brommage R, Jerome CP, Turner CH (2004) Teriparatide [PTH(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity. J Bone Min Res 19:623\u2013629","journal-title":"J Bone Min Res"},{"key":"4890_CR23","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1359\/jbmr.2003.18.11.1932","volume":"18","author":"Y Jiang","year":"2003","unstructured":"Jiang Y, Zhao JJ, Mitlak BH, Wang O, Genant HK, Eriksen EF (2003) Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res 18:1932\u20131941","journal-title":"J Bone Miner Res"},{"key":"4890_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00198-010-1226-1","volume":"22","author":"HM MacDonald","year":"2011","unstructured":"MacDonald HM, Nishiyama KK, Hanley DA, Boyd SK (2011) Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18\u00a0months of teriparatide therapy in postmenopausal women with osteoporosis. Osteoporos Int 22:357\u2013362","journal-title":"Osteoporos Int"},{"key":"4890_CR25","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1002\/jbmr.5650110921","volume":"11","author":"P Augut","year":"1996","unstructured":"Augut P, Reeb H, Claes LE (1996) Prediction of fracture load at different skeletal sites by geometric properties of the cortical shell. J Bone Miner Res 11:1356\u20131363","journal-title":"J Bone Miner Res"},{"key":"4890_CR26","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/jbmr.5650040419","volume":"4","author":"R Eastell","year":"1989","unstructured":"Eastell R, Riggs BL, Wahner HW, O'Fallon WM, Amadio PC, Melton LJ III (1989) Colles\u2019 fracture and bone density of the ultradistal radius. J Bone Miner Res 4:607\u2013613","journal-title":"J Bone Miner Res"},{"key":"4890_CR27","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s001980200114","volume":"13","author":"E Kanterewicz","year":"2002","unstructured":"Kanterewicz E, Ya\u00f1ez A, P\u00e9rez-Pons A, Codony I, Del Rio L, D\u00edez-P\u00e9rez A (2002) Association between Colles\u2019 fracture and low bone mass: age-based differences in postmenopausal women. Osteoporos Int 13:824\u2013828","journal-title":"Osteoporos Int"},{"key":"4890_CR28","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1359\/jbmr.2000.15.3.586","volume":"15","author":"E Van Der Poest Clement","year":"2000","unstructured":"Van Der Poest Clement E, Patka P, Vandormael K, Haarman H, Lips P (2000) The effect of alendronate on bone mass after distal forearm fracture. J Bone Miner Res 15:586\u2013593","journal-title":"J Bone Miner Res"},{"key":"4890_CR29","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434\u20131441","journal-title":"N Engl J Med"},{"key":"4890_CR30","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1359\/jbmr.2003.18.3.539","volume":"18","author":"JR Zanchetta","year":"2003","unstructured":"Zanchetta JR, Bogado CE, Ferretti JL, Wang O, Wilson MG, Sato M, Gaich GA, Dalsky GP, Myers SL (2003) Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis. J Bone Miner Res 18:539\u2013543","journal-title":"J Bone Miner Res"},{"key":"4890_CR31","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/jbmr.1784","volume":"28","author":"S Hansen","year":"2013","unstructured":"Hansen S, Hauge EM, Jensen J-EB, Brixen K (2013) Differing effects of PTH 1-34, PTH 1-84, and zolendronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18-month open-labeled observational study using HR-pQCT. J Bone Miner Res 28:736\u2013745","journal-title":"J Bone Miner Res"},{"key":"4890_CR32","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1210\/jc.2016-1160","volume":"101","author":"JN Tsai","year":"2016","unstructured":"Tsai JN, Uihlein AV, Burnett-Bowie SM, Neer RM, Derrico NP, Lee H, Bouxsein ML, Leder BZ (2016) Effects of two years of teriparatide, denosumab, or both on bone microarchitecture and strength (DATA-HRpQCT study). J Clin Endocrinol Metab 101:2023\u20132030","journal-title":"J Clin Endocrinol Metab"},{"key":"4890_CR33","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1359\/jbmr.1999.14.4.536","volume":"14","author":"T Hirano","year":"1999","unstructured":"Hirano T, Burr DB, Turner CH, Sato M, Cain RL, Hock JM (1999) Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY 333334, on remodeling and mechanical properties of cortical bone in rabbits. J Bone Miner Res 14:536\u2013545","journal-title":"J Bone Miner Res"},{"key":"4890_CR34","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s001980050068","volume":"8","author":"P Augat","year":"1998","unstructured":"Augat P, Fuerst T, Genant HK (1998) Quantitative bone mineral assessment at the forearm: a review. Osteoporos Int 8:299\u2013310","journal-title":"Osteoporos Int"}],"updated-by":[{"DOI":"10.1007\/s00198-020-05469-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000}},{"DOI":"10.1007\/s00198-020-05349-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000}}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-04890-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-019-04890-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-04890-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T07:31:23Z","timestamp":1600327883000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-019-04890-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,21]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6,1]]}},"alternative-id":["4890"],"URL":"https:\/\/doi.org\/10.1007\/s00198-019-04890-2","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00198-020-05469-y","asserted-by":"object"},{"id-type":"doi","id":"10.1007\/s00198-020-05349-5","asserted-by":"object"}]},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,21]]},"assertion":[{"value":"28 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this article, published on 21 March 2019, unfortunately contained a mistake.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2020","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this article, published on 21 March 2019, unfortunately contains some typos in Figs.\ufffd\ufffd2, 3, 4, and Supplemental Fig.\ufffd\ufffd1. The corrected figures are given below.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"NBW: Founder, Osteodynamics, Speaker, Amgen, Speaker, Shire, Consultant, Abbvie, Consultant, Amgen, Consultant, Janssen Pharmaceuticals, Consultant, Radius Health, Inc., Consultant, Sanofi; LAF, GCW, GH: Employee and company stock, Radius Health, Inc.; YW: Employee, Radius Health, Inc.; PDM: Medical Advisory Board Member, Amgen, Medical Advisory Board Member, AgNovos, Medical Advisory Board Member, Lilly USA, LLC, Medical Advisory Board Member, Merck & Co., Medical Advisory Board Member, Radius Health, Inc., Medical Advisory Board Member, Roche Pharmaceuticals, Medical Advisory Board Member, Ultragenyx, Researcher, Alexion, Researcher, Amgen, Researcher, Boehringer Ingelheim, Researcher, Immunodiagnostics, Researcher, Eli Lilly & Company, Researcher, Merck & Co., Researcher, Merck Serono, Researcher, National Bone Health Alliance, Researcher, Novartis Pharmaceuticals, Researcher, Radius Health, Inc., Researcher, Roche Diagnostics, Researcher, Regeneron, Researcher, Daiichi Sankyo, Researcher, Ultragenyx. FC: Advisor, Lilly USA, LLC; Speaker, Lilly USA, LLC; Researcher, Lilly USA, LLC; Advisor, Amgen; Speaker, Amgen; Researcher, Amgen; Advisor, Radius Health, Inc.; Speaker, Radius Health, Inc., Advisor, Merck & Co.; Consultant, Tarsa.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest disclosures"}},{"value":"The original trial upon which this study is based ( Identifier: NCT01343004) was performed in accordance with the ethical standards in the 1964 declaration of Helsinki and with relevant regulations of the US Health Insurance Portability and Accountability Act (HIPAA).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical review committee statement"}}]}}